tiprankstipranks
Trending News
More News >
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market

Intensity Therapeutics, Inc. (INTS) Similar Stocks

Compare
243 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Intensity Therapeutics, Inc.
$0.47
$26.24M
-0.65
-77.18%
3 Buy
0 Hold
0 Sell
Strong Buy
Biodexa Pharmaceuticals
$4.75
$3.12M
-0.08
-88.69%
0 Buy
0 Hold
0 Sell
Moderate Buy
Q/C Technologies
$4.77
$22.29M
-0.03
-95.99%
Salarius Pharmaceuticals
$0.78
$3.37M
-0.07
-96.46%
Scinai Immunotherapeutics
$1.20
$963.88K
0.23
-64.91%
Oragenics
$0.91
$4.66M
-0.04
-90.64%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INTS
Intensity Therapeutics, Inc.
0.47
-1.57
-76.96%
BDRX
Biodexa Pharmaceuticals
4.75
-36.75
-88.55%
QCLS
Q/C Technologies
4.77
-104.23
-95.62%
SLRX
Salarius Pharmaceuticals
0.78
-20.01
-96.25%
SCNI
Scinai Immunotherapeutics
1.20
-2.25
-65.22%
OGEN
Oragenics
0.91
-9.57
-91.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts